Back to Results
First PageMeta Content
Pharmaceutical sciences / Immunosuppressants / Monoclonal antibodies / Ustekinumab / Infliximab / Golimumab / Clinical trial / Biologic / Psoriasis / Centocor / Pharmacology / Medicine


6.5 Golimumab, 50 mg/0.5 mL injection, 1x 0.5 mL, syringe SimponiĀ®; Infliximab, 100 mg injection, 1x 100 mg vial, RemicadeĀ®; Ustekinumab 45 mg/0.5 ml injection, 1x 0.5 ml vial,
Add to Reading List

Document Date: 2015-04-22 23:39:46


Open Document

File Size: 176,09 KB

Share Result on Facebook
UPDATE